AN2 Therapeutics, Inc.

NASDAQ:ANTX

Biotechnology

Healthcare
$5.22 +0.82%

+$0.04 today

Market cap
$198.07M
Beta
-0.98
P/E (TTM)
-4.9
EPS (TTM)
-$1.01
52W Low $1.00High $6.91

Volume 0.79M

Average 0.29M

Price history

AN2 Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+383.33%

Period high

$6.28

Period low

$1.03

Latest

$5.22

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
SC 13G/ANov 13, 2026Nov 13, 2026
8-KNov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
4Nov 6, 2026Nov 6, 2026
4Oct 13, 2026Oct 13, 2026
4Oct 13, 2026Oct 13, 2026
4Oct 13, 2026Oct 13, 2026
4Sep 16, 2026Sep 16, 2026
S-8Sep 14, 2026Sep 14, 2026
4Sep 11, 2026Sep 11, 2026
4Sep 8, 2026Sep 8, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 2, 2026Sep 2, 2026
3Aug 27, 2026Aug 27, 2026

Competitors

Who does AN2 Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ANTX's filings, answered from its disclosures.

What is the latest ANTX filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does ANTX have?

Intrinsic Alpha currently shows 20 recent filings for ANTX.